The Food and Drug Administration (FDA) on Thursday approved a higher dose of the Wegovy weight loss drug. The manufacturer, Novo Nordisk, increased the semaglutide injection by 4.8 mg to total 7.2 mg. The company says the higher dosage is recommended for those who taken the lower dose already for at least four weeks. Novo Nordisk…
FDA approves higher dose of Wegovy
Originally reported by The Hill
Related Articles
Trump does not plan to bar oil or gas exports, say Burgum and Wright
The Trump administration will not restrict U.S. exports of oil or natural gas amid rising prices over the war in Iran, t...
Frost: Mullin accepting DHS nomination ‘shows us who he is’
Rep. Maxwell Frost (D-Fla.) weighed in on President Trump’s decision to tap Sen. Markwayne Mullin (R-Okla.) to lea...
Warren Endorses Platner in Maine, Splitting With Schumer
The intervention by Ms. Warren is the latest instance of her embracing a candidate at odds with Mr. Schumer, the top Sen...
Judge dismisses Trump administration lawsuit over California egg prices
A federal judge on Wednesday dismissed a lawsuit brought by the Trump administration against California last summer over...